DIANE MITCHELL: Open Payments
NPI 1730247826 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 6 payments from 5 companies in 2025. Trend: 2023 $699 · 2024 $569 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $257 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Eisai Inc. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| GlaxoSmithKline, LLC. | 1 | $103 |
Products named: REZDIFFRA, STRENSIQ, Leqembi, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
